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The sequential 1,4-elimination reaction of (E)-4-alkoxy-2-butenyl benzoates and 
[1,2]-Wittig rearrangement gave (2Z,4E)-2,4-pentadien-1-ols stereoselectively. 
Z-Selective formation of intermediary vinyl ethers, whose stereochemistry was well 
elucidated by the “syn-effect,” was achieved by treatment of the 2-butenyl benzoates 
  2 
with KOH in the presence of Pd catalyst. The subsequent [1,2]-Wittg rearrangement by 




Stereoselective synthesis of carbon-carbon double bonds as ubiquitous and versatile 
two-carbon units is among the most important and challenging tasks in organic 
chemistry.1 Consequently, a large number of synthetic methodologies have been 
reported, e.g., 1) Wittig reaction, which utilizes the characteristics of phosphorus,2 2) 
Peterson reaction, which utilizes silicon,3 3) Julia olefination, which utilizes sulfones,4,5 
4) reduction or carbometalation of alkynes, which takes advantage of organometallic 
reagents,6 and 5) olefin metathesis, which is realized by the use of Grubbs catalysts.7 
However, these reactions depend on new C–C bond formation or reductive olefin 
formation from alkynes. On the other hand, while the elimination reaction is also a 
powerful method for the preparation of olefins, the stereochemistry of the products 
generally depends on the reaction pathway, i.e., E2 anti-elimination, syn-elimination, or 
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E1 elimination. Therefore, few methods have been reported for stereoselective synthesis 
of olefins using simple elimination reactions.8 
In our laboratory, stereoselective formation of sterically unfavorable (Z)-olefins was 
investigated with various types of elimination and isomerization reactions by treatment 
with a base.9 We proposed that Z-selectivity was achieved by the “syn-effect,” namely a 
stereoelectronic effect owing to σC-H→π*C=C interaction as depicted in Scheme 1, in 
which the transition state of the 1,4-elimination of an allylic sulfone is depicted.9c 
Furthermore, it was found that Z-selectivity based on the “syn-effect” was enhanced 
when the δ-substituent (R1 in Scheme 1) was an electron-withdrawing alkoxy or 
halogen group. 
 
Scheme 1. Concept of the ‘‘Syn-effect’’: σ→π * Interaction in the Elimination 
































(Z-selectivity by R1: 
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This methodology could then be applied to a stereoselective synthesis of (Z)-olefins 
in combination with C–C bond formation. We have reported a sequential 
1,4-elimination reaction of δ-benzyloxy-substituted allylic sulfones followed by 
[1,2]-Wittig rearrangement10 to give (Z)-dienyl alcohols (2,4-pentadien-1-ols), which 
are useful synthetic intermediates due to the presence of both an allylic alcohol moiety 
and a diene moiety (Scheme 2a).11 However, the reaction was limited to only 
α,α-disubstituted allylic sulfones. When an α-monosubstituted allylic sulfone was 
subjected to the reaction, the elimination of the benzyloxy group proceeded 
preferentially via deprotonation of the more acidic α-proton (Scheme 2b).12 In this 
situation, the stereocontrolled preparation of 
(2Z)-5-monosubstituted-2,4-pentadien-1-ols still remained to be solved. Previously, we 
found that (1Z,3E)-1,3-dienes were produced stereoselectively in the Pd-catalyzed 
elimination reaction of acyclic (E)-allylic acetates with a base.9g We anticipated this 
protocol would be applicable to the sequential 1,4-elimination reaction and [1,2]-Wittig 
rearrangement. Herein we describe the sequential reaction of stereoselective 
1,4-elimination of (E)-4-alkoxy-2-butenyl benzoates via the π-allylic palladium 
5 
complex and subsequent [1,2]-Wittig rearrangement to afford (2Z, 
4E)-5-monosubstituted-2,4-pentadien-1-ols (Scheme 2c). 












































































RESULTS AND DISCUSSION 
We chose (E)-4-benzyloxy-1-phenyl-2-butenyl benzoate (1a) as a model substrate 
for the optimization of the reaction conditions.13,14 Under our previously reported 
conditions for allylic acetates using DBU, the Pd-catalyzed [1,4]-elimination reaction of 
1a did not proceed reproducibly. Deactivation of the Pd(0) complex by molecular 
oxygen contamination was suspected as the cause. In order to prevent this deactivation, 
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degassed THF was used as the solvent, and the 1,4-elimination reaction was found to 
proceed reproducibly. After the 1,4-elimination by treatment with DBU,15 an excess 
amount of n-BuLi was added to the reaction mixture to give the desired (2Z,4E)-dienyl 
alcohol 2a in good yield with high Z-selectivity at the C2–C3 double bond (Table 1, 
Entry 1).16 However, a large excess (12 equiv) of n-BuLi was required to complete the 
[1,2]-Wittig rearrangement.17 The search for a base that did not react with n-BuLi 
revealed that NaOt-Bu could reduce the amount of n-BuLi to 7 equiv for the 
[1,2]-Wittig rearrangement (Entry 2). However, the desired product 2a was not obtained 
with NaOt-Bu or KOt-Bu purified by sublimation (Entries 3 and 4). We supposed the 
actual base might be NaOH or KOH, which was generated by partial hydrolysis of 
NaOt-Bu or KOt-Bu. Therefore, we employed NaOH and KOH as bases for the initial 
elimination. To our delight, elimination proceeded18 reproducibly and further treatment 
with n-BuLi (6 equiv) gave 2a in good yield with excellent Z-selectivity at the C2–C3 
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1a 2a  
Entry Base n Yield/%    Z/Ea 
1 DBU 12   84   10/1 
2 NaOt-Bu  7  < 82   10/1 
3 NaOt-Bub - complicated   - 
4 KOt-Bub - complicated   - 
 5c NaOH  6   73   10/1 
 6c KOH  6   68 >20/1 
aThe ratios were determined by 400 MHz 1H NMR spectra. Stereochemistries at C4=C5 
were E.  
bSublimed NaOt-Bu or KOt-Bu was used. 
cMS4A was added after elimination reaction. 
 
Under the optimized conditions, the sequential 1,4-elimination reaction and 
[1,2]-Wittig rearrangement of various substrates were performed (Table 2). Benzyl type 
ethers 1b–1d with o-, m-, and p-methyl groups produced the corresponding 
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(2Z,4E)-dienyl alcohols 2b–2d (Entries 2-4). When 2-butenyl benzoates 1e and 1f, 
bearing electron-donating or electron-withdrawing groups on the aromatic ring were 
employed, the desired products were also obtained with excellent Z-selectivities (Entries 
5 and 6). 4-(2-Naphthylmethyloxy)butenyl benzoate 1g was also converted into the 
corresponding (2Z,4E)-dienyl alcohol 2g (Entry 7). Next, we examined the generality of 
the sequential reaction for (E)-2-butenyl benzoates bearing various substituents at the 
α-position of the butenyl group. The desired products 2h–2j were obtained in good 
yields with excellent Z-selectivities from 2-butenyl benzoates 1h–1j bearing an aryl or 
t-Bu substituent on the α-carbon (Entries 8–10). However, in the case of a benzoate 1k 
with an i-Pr group at the α-position of the butenyl group, dienyl alcohol 2k was 
obtained in low yield, while excellent Z-selectivity was retained. In this case, 
by-product 3, derived from deprotonation of not Hδ but Hβ’ followed by [1,2]-Wittig 
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1 2  
Entry Ar R  Yield/%    Z/Ea 
1 Ph Ph a 68 >20/1 
2 2-MeC6H4 Ph b 65   18/1 
3 3-MeC6H4 Ph c 58 >20/1 
4 4-MeC6H4 Ph d 63 >20/1 
5 4-MeOC6H4 Ph e 71   19/1 
6 4-ClC6H4 Ph f 63   15/1 
7 2-Naph Ph g 68 >20/1 
8 Ph 4-MeC6H4 h 72 >20/1 
9 Ph 2-Naph i 67    17/1 
10 Ph t-Bu j 53 >20/1 
11 Ph i-Pr k 34 >20/1 
aThe ratios were determined by 400 MHz 1H NMR spectra. Stereochemistries at C4=C5 
were E. 
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Scheme 3. Generation of By-product 3 in the Reaction of 2-Butenyl Benzoate 1k 








































In conclusion, we achieved a stereoselective synthesis of (2Z,4E)-2,4-pentadien-1-ols 
via sequential 1,4-elimination reaction and [1,2]-Wittig rearrangement starting from 
(E)-4-alkoxy-2-butenyl benzoates. The present method would be applicable in synthetic 
chemistry, because the stereochemistry can be predicted correctly by universal 
stereoelectronic effects.20 Development of other Z-selective reactions based on this 
strategy is currently underway in our laboratory. 
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Experimental Section 
General Method. 1H NMR spectra were recorded on a 400 MHz NMR spectrometer. 
Chemical shifts δ are reported in ppm using TMS as an internal standard. Data are 
reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet), coupling constant (J) and integration. 13C NMR spectra were 
recorded on a 100 MHz NMR spectrometer. The chemical shifts are reported relative to 
CDCl3 (δ = 77.0 ppm). The wavenumbers of maximum absorption peaks in IR spectra 
are presented in cm−1. HRMS (EI positive, ESI-TOF) spectra were measured with 
quadrupole and TOF mass spectrometers. All of the melting points were measured with 
a micro melting point apparatus. THF was freshly distilled from sodium diphenylketyl. 
THF used for 1,4-elimination was degassed by three freeze-pump-thaw cycles prior to 
use. DMF was distilled and stored over drying agents.  
 
(E)-4-Alkoxy-2-butenyl benzoates 1 were prepared from the corresponding propargyl 
ethers and aldehydes according to the following scheme. 
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OAr
OAr R
OH1) n-BuLi (1.0 equiv)












THF, –40 °C to rt
DMF, rt
THF, –78 °C to rt
 
Representative Procedure for Preparation of 4-Alkoxy-2-butyn-1-ol 4a:  
To a solution of benzyl propargyl ether (4.00 g, 27.4 mmol) in THF (45 mL), n-BuLi 
(16.9 mL of 1.62 M solution in hexane, 27.4 mmol) was added dropwise at –78 °C. 
After stirring for 20 min, benzaldehyde (3.19 g, 30.1 mmol) was added and the resulted 
solution was stirred for 30 min at –78 °C, warmed to rt, and stirred for 3 h.21 The 
reaction mixture was quenched with a sat. aq solution of NH4Cl. After evaporating the 
solvent, the aqueous layer was separated and extracted with Et2O. The combined 
organic extracts were washed with H2O, brine, and dried over Na2SO4. The crude 
product was purified by silica gel column chromatography (hexane/AcOEt = 5/1) to 
give 4a (6.01 g, 87%) as an oil. 
 
In a similar manner, 4-alkoxy-2-butyn-1-ols 4b–4k were prepared from the 
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corresponding propargyl ethers. 
 
4-(Benzyloxy)-1-phenyl-2-butyn-1-ol (4a)21 
1H NMR (400 MHz, CDCl3): 2.25 (d, J = 5.9 Hz, 1H), 4.27 (d, J = 1.8 Hz, 2H), 4.61 (s, 
2H), 5.53 (d, J = 5.9 Hz, 1H) 7.28－7.41 (m, 8H), 7.55 (d, J = 7.3 Hz, 2H). 13C NMR 
(100 MHz, CDCl3): 57.0, 63.9, 71.3, 81.8, 86.3, 126.3, 127.6, 127.8, 128.0, 128.1, 
128.2, 136.8, 140.2. IR (neat): 3390, 3062, 3030, 2857, 2227, 1644, 1494, 1454, 1387, 
1354, 1313, 1264, 1193, 1120, 1071, 1026, 918, 738, 698 cm–1. HRMS (EI): Calcd for 
C17H16O2 [M+ ]: 252.1150. Found: 252.1155. 
 
4-((2-Methylbenzyl)oxy)-1-phenyl-2-butyn-1-ol (4b) 
4b (3.63 g, 91% from 15.0 mmol of 2-methylbenzyl propargyl ether) was obtained as an 
oil. 1H NMR (400 MHz, CDCl3): 2.25 (d, J = 6.0 Hz, 1H), 2.34 (s, 3H), 4.28 (d, J = 1.8 
Hz, 2H), 4.60 (s, 2H), 5.53 (d, J = 6.0 Hz, 1H) 7.15－7.24 (m, 3H), 7.25－7.43 (m, 4H) 
7.54 (d, J = 6.9 Hz, 2H). 13C NMR (100 MHz, CDCl3): 18.6, 57.3, 64.2, 69.8, 82.2, 86.4, 
125.6, 126.4, 128.0, 128.1, 128.4, 129.0, 130.1, 134.9, 136.9, 140.3. IR (neat): 3391, 
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3063, 3029, 2864, 2235, 1604, 1493, 1454, 1353, 1262, 1189, 1121, 1072, 945, 918, 




4c (2.81 g, 86% from 12.3 mmol of 3-methylbenzyl propargyl ether) was obtained as an 
oil. 1H NMR (400 MHz, CDCl3): 2.21 (d, J = 5.9 Hz, 1H), 2.35 (s, 3H), 4.27 (d, J = 1.8 
Hz, 2H), 4.57 (s, 2H), 5.53 (d, J = 5.9 Hz, 1H), 7.11－7.17 (m, 2H), 7.23 (d, J = 7.4 Hz, 
1H), 7.32－7.42 (m, 3H), 7.55 (d, J = 6.9 Hz, 2H). 13C NMR (100 MHz, CDCl3): 21.1, 
57.0, 64.0, 71.3, 82.0, 86.4, 125.0, 126.4, 128.0, 128.1, 128.3, 128.4, 128.6, 136.8, 
137.8, 140.0. IR (neat): 3391, 3029, 2857, 2230, 1492, 1454, 1380, 1353, 1255, 1192, 
1157, 1120, 1078, 1003, 918, 785, 742, 698 cm–1. HRMS (EI): Calcd for C18H18O2 
[M+ ]: 266.1307. Found: 266.1305. 
 
4-((4-Methylbenzyl)oxy)-1-phenyl-2-butyn-1-ol (4d) 
4d (2.79 g, 92% from 11.4 mmol of 4-methylbenzyl propargyl ether) was obtained as an 
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oil. 1H NMR (400 MHz, CDCl3): 2.23 (d, J = 6.0 Hz, 1H), 2.34 (s, 3H), 4.24 (d, J = 1.8 
Hz, 2H), 4.57 (s, 2H), 5.53 (d, J = 6.0 Hz, 1H), 7.15 (d, J = 7.8 Hz, 2H), 7.23 (d, J = 7.8 
Hz, 2H), 7.32－7.41 (m, 3H), 7.55 (d, J = 6.9 Hz, 2H). 13C NMR (100 MHz, CDCl3): 
21.3, 57.3, 64.4, 71.6, 82.5, 86.8, 126.8, 128.4, 128.5, 128.7, 129.3, 134.2, 137.8, 140.7. 
IR (neat): 3392, 3029, 2857, 2230, 1903, 1515, 1493, 1453, 1382, 1354, 1309, 1262, 
1193, 1120, 1077, 1021, 945, 918, 843, 806, 754, 732, 699 cm–1. HRMS (EI): Calcd for 
C18H18O2 [M+ ]: 266.1307. Found: 266.1306. 
 
4-((4-Methoxybenzyl)oxy)-1-phenyl-2-butyn-1-ol (4e) 
4e (1.36 g, 89% from from 5.4 mmol of 4-methoxybenzyl propargyl ether) was obtained 
as an oil. 1H NMR (400 MHz, CDCl3): 2.21 (br, 1H), 3.80 (s, 3H), 4.23 (d, J = 1.2 Hz, 
2H), 4.54 (s, 2H), 5.53 (s, 1H), 6.87 (d, J = 8.7 Hz, 2H), 7.27 (d, J = 8.7 Hz, 2H) 7.32－
7.41 (m, 3H), 7.55 (d, J = 6.9 Hz, 2H). 13C NMR (100 MHz, CDCl3): 55.3, 57.1, 64.4, 
71.3, 82.5, 86.7, 113.9, 126.7, 128.4, 128.7, 129.3, 130.0, 140.7, 159.4. IR (neat): 3401, 
3062, 3031, 2837, 2226, 1612, 1585, 1512, 1493, 1455, 1354, 1302, 1249, 1175, 1118, 
1074, 1032, 918, 818, 759, 700 cm–1. HRMS (EI): Calcd for C18H18O3 [M+ ]: 282.1256. 




4f (2.67 g, 85% from 11.0 mmol of 4-chlorobenzyl propargyl ether) was obtained as an 
oil. 1H NMR (400 MHz, CDCl3): 2.18 (br, 1H), 4.27 (d, J = 1.8 Hz, 2H), 4.57 (s, 2H), 
5.54 (s, 1H), 7.27－7.42 (m, 7H), 7.54 (d, J = 6.4 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): 57.4, 64.2, 70.7, 82.0, 86.6, 126.4, 128.0, 128.2, 128.4, 129.2, 133.5, 135.5, 
140.3. IR (neat): 3378, 3031, 2861, 1598, 1540, 1491, 1455, 1408, 1354, 1262, 1193, 
1120, 1086, 1015, 918, 841, 806, 733, 699, 674 cm–1. HRMS (EI): Calcd for 
C17H15ClO2 [M+ ]: 286.0761. Found: 286.0765. 
 
4-(2-Naphthalenylmethoxy)-1-phenyl-2-butyn-1-ol (4g) 
4e (1.86 g, 73% from 8.4 mmol of 4-methoxybenzyl propargyl ether) was obtained as 
an oil. 1H NMR (400 MHz, CDCl3): 2.23 (br, 1H), 4.31 (d, J = 1.8 Hz, 2H), 4.78 (s, 2H), 
5.54 (s, 1H), 7.33－7.42 (m, 3H), 7.46－7.49 (m, 3H), 7.55－7.57 (m, 2H), 7.80－7.84 
(m, 4H). 13C NMR (100 MHz, CDCl3): 57.2, 64.3, 71.6, 82.3, 86.5, 125.8, 125.9, 126.0, 
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126.5, 126.9, 127.5, 127.8, 128.1, 128.2, 128.5, 132.9, 133.0, 134.5, 140.3. IR (neat): 
3381, 3057, 2854, 2230, 1601, 1509, 1492, 1454, 1355, 1271, 1173, 1123, 1078, 1003, 




4h (2.13 g, 76% from 10.5 mmol of benzyl propargyl ether) was obtained as an oil. 1H 
NMR (400 MHz, CDCl3): 2.15 (d, J = 6.0 Hz, 1H), 2.36 (s, 3H), 4.27 (d, J = 1.8 Hz, 
2H), 4.61 (s, 2H), 5.49 (d, J = 6.0 Hz, 1H), 7.20 (d, J = 7.8 Hz, 2H), 7.29－7.38 (m, 5H), 
7.43 (d, J = 7.8 Hz, 2H). 13C NMR (100 MHz, CDCl3): 20.9, 57.1, 63.8, 71.3, 81.7, 86.7, 
126.3, 127.6, 127.9, 128.2, 128.9, 136.9, 137.5, 137.7. IR (neat): 3396, 3029, 2858, 
2235, 1511, 1496, 1454, 1354, 1264, 1196, 1178, 1114, 1071, 1026, 942, 821, 742, 699 
cm–1. HRMS (EI): Calcd for C18H18O2 [M+ ]: 266.1307. Found: 266.1300. 
 
4-(Benzyloxy)-1-(2-naphthalenyl)-2-butyn-1-ol (4i) 
4i (1.44 g, 81% from 5.8 mmol of benzyl propargyl ether) was obtained as an oil. 1H 
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NMR (400 MHz, CDCl3): 2.34 (br, 1H), 4.30 (d, J = 0.92 Hz, 2H), 4.63 (s, 2H), 5.69 (s, 
1H), 7.28－7.35 (m, 5H), 7.47－7.52 (m, 2H), 7.66 (d, J = 8.2 Hz, 1H), 7.82－7.89 (m, 
3H), 8.00 (s, 1H). 13C NMR (100 MHz, CDCl3): 57.1, 64.2, 71.4, 82.3, 86.4, 124.4, 
125.1, 126.0, 127.4, 127.7, 127.9, 127.9, 128.0, 128.2, 128.3, 132.9, 133.0, 136.9, 137.7. 
IR (neat): 3375, 3057, 2857, 2225, 1601, 1507, 1495, 1455, 1355, 1269, 1167, 1113, 
1071, 1025, 951, 903, 861, 821, 748, 699 cm–1. HRMS (EI): Calcd for C21H18O2 [M+ ]: 
302.1307. Found: 302.1306. 
 
6-(Benzyloxy)-2,2-dimethyl-4-hexyn-3-ol (4j)22 
4j (1.16 g, 42% from 11.9 mmol of benzyl propargyl ether) was obtained as an oil. 1H 
NMR (400 MHz, CDCl3): 1.01 (s, 9H), 1.72 (br, 1H), 4.07 (s, 1H), 4.23 (d, J = 1.8 Hz, 
2H), 4.60 (s, 2H), 7.26－7.36 (m, 5H). 13C NMR (100 MHz, CDCl3): 25.2, 35.6, 57.2, 
71.1, 71.3, 81.2, 86.3, 127.7, 128.0, 128.3, 137.2. IR (neat): 3446, 3030, 2956, 2867, 
2215, 1540, 1478, 1455, 1363, 1321, 1240, 1123, 1072, 1008, 936, 743, 698 cm–1. 
HRMS (EI): Calcd for C15H20O2 [M+ ]: 232.1463. Found: 232.1464. 
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6-(Benzyloxy)-2-methyl-4-hexyn-3-ol (4k)22 
4k (2.53 g, 94% from 12.3 mmol of benzyl propargyl ether) was obtained as an oil. 1H 
NMR (400 MHz, CDCl3): 1.01 (d, J = 7.3 Hz, 3H), 1.03 (d, J = 7.3 Hz, 3H), 1.60 (br, 
1H), 1.89 (br, 1H), 4.24 (d, J = 5.0 Hz, 2H) 4.23－4.25 (m, 1H), 4.60 (s, 2H), 7.28－
7.36 (m, 5H). 13C NMR (100 MHz, CDCl3): 17.3, 18.0, 34.2, 57.2, 67.6, 71.3, 81.1, 
86.4, 127.7, 128.0, 128.3, 137.1. IR (neat): 3402, 3031, 2962, 2872, 2215, 1496, 1455, 
1384, 1352, 1261, 1207, 1144, 1073, 1027, 936, 743, 699 cm–1. HRMS (EI): Calcd for 
C14H18O2 [M+ ]: 218.1307. Found: 218.1311. 
 
Representative Procedure for Preparation of (E)-4-Alkoxy-2-butenyl Benzoate 1a:  
To a solution of compound 4a (2.52 g, 10 mmol) in THF (20 mL), Red-Al (5.6 mL of 
3.6 M solution in toluene, 20 mmol) was added dropwise at –40 °C. The reaction 
mixture was warmed to room temperature and stirred for 3 h. The reaction mixture was 
quenched with a satd. aq solution of Na2SO4. After insoluble substrate was filtered off 
through celite, the solvent was evaporated. The residue was passed through silica gel 
short column (hexane/AcOEt = 2/1) to afford the almost pure (E)-2-buten-1-ol 5a23 
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(2.53 g). This material was used for the conversion to the corresponding benzoate 1a 
without further purification. To a solution of the obtained 5a (2.53 g) in DMF (40 mL) 
were added Et3N (2.02 g, 20 mmol), benzoyl chloride (1.40 g, 10 mmol), and DMAP 
(610 mg, 5 mmol) at rt and the resulted solution was stirred overnight. The reaction 
mixture was quenched with a sat. aq solution of NH4Cl. The aqueous layer was 
separated and extracted with AcOEt. The combined organic extracts were washed with 
H2O, brine, and dried over Na2SO4. The crude product was purified by silica gel column 
chromatography (hexane/AcOEt = 15/1) to give 1a (2.51 g, 70% for 2 steps) as an oil. 
 
In similar manner, (E)-4-alkoxy-2-butenyl benzoates 1b–1k were prepared from the 
corresponding 4-alkoxy-2-butyn-1-ols 4b–4k. 
 
(E)-4-(Benzyloxy)-1-phenyl-2-buten-1-yl benzoate (1a) 
1H NMR (400 MHz, CDCl3): 4.07 (d, J = 5.5 Hz, 2H), 4.52 (s, 2H), 5.96 (dt, J = 15.6, 
5.5 Hz, 1H), 6.04 (dd, J = 15.6, 6.0 Hz, 1H), 6.54 (d, J = 6.0 Hz, 1H), 7.26－7.58 (m, 
13H), 8.09 (d, J = 6.8 Hz, 2H). 13C NMR (100 MHz, CDCl3): 69.6, 72.3, 75.9, 127.0, 
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127.6, 127.7, 128.1, 128.3, 128.5, 128.6, 129.5, 129.6, 130.1, 130.6, 133.0, 137.9, 139.0, 
165.4. IR (neat): 3063, 3031, 2855, 1717, 1600, 1584, 1494, 1452, 1315, 1267, 1176, 
1107, 1069, 1025, 968, 751, 712 cm–1. HRMS (EI): Calcd for C24H22O3 [M+ ]: 358.1569. 
Found: 358.1573. 
 
(E)-4-((2-Methylbenzyl)oxy)-1-phenyl-2-buten-1-yl benzoate (1b) 
Starting from 5.0 mmol of 4b, almost pure 5b (1.22 g) was obtained. Then 708 mg of 
the intermediary 5b was used to give 1b (644 mg, 61% for 2 steps) as an oil. 1H NMR 
(400 MHz, CDCl3): 2.30 (s, 3H), 4.08 (d, J = 5.0 Hz, 2H), 4.50 (s, 2H), 5.97 (dt, J = 
15.6, 5.0 Hz, 1H), 6.05 (dd, J = 15.6, 5.5 Hz, 1H), 6.54 (d, J = 5.5 Hz, 1H), 7.15－7.58 
(m, 12H), 8.09 (d, J = 9.6 Hz, 2H). 13C NMR (100 MHz, CDCl3): 18.7, 69.7, 70.5, 75.8, 
125.6, 126.9, 127.7, 128.1, 128.3, 128.5, 129.6, 130.1, 130.6, 132.9, 135.8, 136.6, 139.0, 
165.3. IR (neat): 3063, 3031, 2855, 1719, 1601, 1493, 1452, 1314, 1266, 1176, 1107, 
1070, 1025, 968, 746, 712 cm–1. HRMS (EI): Calcd for C25H24O3 [M+ ]: 372.1725. 
Found: 372.1728. 
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(E)-4-((3-Methylbenzyl)oxy)-1-phenyl-2-buten-1-yl benzoate (1c) 
Starting from 5.5 mmol of 4c, almost pure 5c (1.33 g) was obtained. Then 707 mg of 
the intermediary 5c was used to give 1c (678 mg, 69% for 2 steps) as an oil. 1H NMR 
(400 MHz, CDCl3): 2.33 (s, 3H), 4.06 (d, J = 5.5 Hz, 2H), 4.47 (s, 2H), 5.97 (dt, J = 
15.5, 5.5 Hz, 1H), 6.05 (dd, J = 15.5, 5.9 Hz, 1H), 6.54 (d, J = 5.9 Hz, 1H), 7.09－7.58 
(m, 12H), 8.09 (d, J = 7.3 Hz, 2H). 13C NMR (100 MHz, CDCl3): 21.3, 69.7, 72.4, 75.9, 
124.9, 127.0, 128.1, 128.2, 128.3, 128.4, 128.6, 129.6, 129.7, 130.1, 130.7, 133.0, 137.8, 
137.9, 139.0, 165.4. IR (neat): 3061, 3031, 2919, 2855, 1718, 1601, 1585, 1492, 1451, 
1314, 1266, 1176, 1158, 1107, 1069, 1025, 968, 907, 780, 757, 712 cm–1. HRMS (EI): 
Calcd for C25H24O3 [M+ ]: 372.1725. Found: 372.1721. 
 
(E)-4-((4-Methylbenzyl)oxy)-1-phenyl-2-buten-1-yl benzoate (1d) 
Starting from 6.4 mmol of 4d, almost pure 5d (1.45 g) was obtained. Then 570 mg of 
the intermediary 5d was used to give 1d (546 mg, 58% for 2 steps) as an oil. 1H NMR 
(400 MHz, CDCl3): 2.33 (s, 3H), 4.04 (d, J = 5.5 Hz, 2H), 4.46 (s, 2H), 5.95 (dt, J = 
15.5, 5.5 Hz, 1H), 6.02 (dd, J = 15.5, 6.0 Hz, 1H), 6.53 (d, J = 6.0 Hz, 1H), 7.10－7.58 
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(m, 12H), 8.10 (d, J = 7.3 Hz, 2H). 13C NMR (100 MHz, CDCl3): 21.1, 69.5, 72.2, 75.9, 
127.0, 127.9, 128.1, 128.3, 128.6, 129.0, 129.7, 130.2, 130.6, 133.0, 133.5, 134.9, 137.3, 
139.1, 165.5. IR (neat): 3031, 2921, 2856, 1719, 1601, 1515, 1493, 1451, 1315, 1267, 
1176, 1107, 1070, 1025, 969, 806, 756, 712 cm–1. HRMS (EI): Calcd for C25H24O3 
[M+ ]: 372.1725. Found: 372.1726.  
 
(E)-4-((4-Methoxybenzyl)oxy)-1-phenyl-2-buten-1-yl benzoate (1e) 
Starting from 3.6 mmol of 4e, almost pure 5e (986 mg) was obtained. Then 781 mg of 
the intermediary 5e was used to give 1e (619 mg, 56% for 2 steps) as an oil. 1H NMR 
(400 MHz, CDCl3): 3.80 (s, 3H), 4.03 (d, J = 5.5 Hz, 2H), 4.44 (s, 2H), 5.95 (dt, J = 
15.6, 5.5 Hz, 1H), 6.03 (dd, J = 15.6, 5.5 Hz, 1H), 6.54 (d, J = 5.5 Hz, 1H), 6.86 (d, J = 
8.7 Hz, 2H), 7.22－7.58 (m, 10H), 8.09 (d, J = 8.2 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): 55.2, 69.4, 72.0, 75.9, 113.7, 127.0, 128.1, 128.3, 128.6, 129.4, 129.7, 130.0, 
130.2, 130.6, 133.0, 139.1, 159.2, 165.4. IR (neat): 3062, 3032, 2934, 2836, 1718, 1612, 
1585, 1512, 1493, 1452, 1361, 1314, 1266, 1175, 1107, 1026, 968, 820, 756, 713 cm–1. 
HRMS (EI): Calcd for C25H24O4 [M+ ]: 388.1675. Found: 388.1683. 
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(E)-4-((4-Chlorobenzyl)oxy)-1-phenyl-2-buten-1-yl benzoate (1f) 
Starting from 7.0 mmol of 4f, almost pure 5f (1.87 g) was obtained. Then 800 mg of the 
intermediary 5f was used to give 1f (783 mg, 67% for 2 steps) as an oil. 1H NMR (400 
MHz, CDCl3): 4.05 (d, J = 5.5 Hz, 2H), 4.46 (s, 2H), 5.95 (dt, J = 16.4, 5.5 Hz, 1H), 
6.03 (dd, J = 16.4, 5.9 Hz, 1H), 6.53 (d, J = 5.9 Hz, 1H), 7.25-7.59 (m, 12H), 8.09 (d, J 
= 8.9 Hz, 2H). 13C NMR (100 MHz, CDCl3): 69.8, 71.5, 75.8, 126.9, 128.1, 128.3, 
128.4, 128.6, 129.0, 129.3, 129.6, 130.1, 130.8, 133.0, 133.3, 136.5, 138.9, 165.4. IR 
(neat): 3062, 3032, 2854, 1718, 1600, 1584, 1491, 1451, 1396, 1314, 1267, 1200, 1176, 
1108, 1025, 1015, 968, 841, 807, 757, 712 cm–1. HRMS (EI): Calcd for C24H21ClO3 
[M+ ]: 392.1179. Found: 392.1175. 
 
(E)-4-(2-Naphthalenylmethoxy)-1-phenyl-2-buten-1-yl benzoate (1g) 
Starting from 5.5 mmol of 4g, almost pure 5g (1.35 g) was obtained. Then 802 mg of 
the intermediary 5g was used to give 1g (463 mg, 35% for 2 steps) as an oil. 1H NMR 
(400 MHz, CDCl3): 4.11 (d, J = 5.5 Hz, 2H), 4.67 (s, 2H), 5.98 (dt, J = 15.5, 5.5 Hz, 
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1H), 6.06 (dd, J = 15.5, 5.5 Hz, 1H), 6.55 (d, J = 5.5 Hz, 1H), 7.30－7.58 (m, 11H), 
7.75－7.84 (m, 4H), 8.09 (d, J = 8.2 Hz, 2H). 13C NMR (100 MHz, CDCl3): 69.7, 72.4, 
75.9, 125.7, 125.8, 126.0, 126.5, 127.0, 127.6, 127.8, 128.1, 128.3, 128.6, 129.5, 129.6, 
130.1, 130.7, 132.8, 132.9, 133.1, 135.4, 139.0, 165.4. IR (neat): 3058, 2852, 1716, 
1601, 1508, 1492, 1451, 1314, 1267, 1175, 1107, 1069, 1025, 966, 856, 818, 753, 712 
cm–1. HRMS (EI): Calcd for C28H24O3 [M+ ]: 408.1725. Found: 408.1729. 
 
(E)-4-(Benzyloxy)-1-(4-tolyl) -2-buten-1-yl benzoate (1h) 
Starting from 5.2 mmol of 4h, almost pure 5h (1.32 g) was obtained. Then 715 mg of 
the intermediary 5f was used to give 1h (615 mg, 58% for 2 steps) as an oil. 1H NMR 
(400 MHz, CDCl3): 2.34 (s, 3H), 4.06 (d, J = 5.0 Hz, 2H), 4.50 (s, 2H), 5.95 (dt, J = 
15.5, 5.0 Hz, 1H), 6.03 (dd, J = 15.5, 5.5 Hz, 1H), 6.50 (d, J = 5.5 Hz, 1H), 7.16-7.57 
(m, 12H), 8.08 (d, J = 6.8 Hz, 2H). 13C NMR (100 MHz, CDCl3): 21.2, 69.8, 72.3, 75.9, 
127.1, 127.6, 127.8, 128.3, 128.4, 128.6, 129.2, 129.3, 129.7, 130.2, 130.9, 133.0, 136.0, 
138.0, 165.5. IR (neat): 3030, 2921, 2857, 1717, 1601, 1514, 1495, 1452, 1315, 1267, 
1176, 1108, 1069, 1025, 968, 816, 737, 711 cm–1. HRMS (EI): Calcd for C25H24O3 
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[M+ ]: 372.1725. Found: 372.1730. 
 
(E)-4-(Benzyloxy)-1-(2-naphthalenyl)-2-buten-1-yl benzoate (1i) 
Starting from 4.8 mmol of 4i, almost pure 5i (1.29 g) was obtained. Then 667 mg of the 
intermediary 5i was used to give 1i (528 mg, 53% for 2 steps) as an oil. 1H NMR (400 
MHz, CDCl3): 4.08 (d, J = 5.5 Hz, 2H), 4.51 (s, 2H), 5.99 (dt, J = 15.5, 5.5 Hz, 1H), 
6.13 (dd, J = 15.5, 5.9 Hz, 1H), 6.71 (d, J = 5.9 Hz, 1H), 7.24－7.61 (m, 11H), 7.80－
7.93 (m, 4H), 8.12 (d, J = 7.3 Hz, 2H). 13C NMR (100 MHz, CDCl3): 70.7, 73.3, 77.0, 
125.7, 127.10, 127.16, 127.19, 128.6, 128.7, 129.0, 129.3, 129.4, 130.6, 130.7, 131.1, 
131.5, 133.9, 134.0, 137.3, 138.8, 166.4. IR (neat): 3059, 2853, 1717, 1601, 1508, 1452, 
1361, 1314, 1266, 1175, 1106, 1069, 1025, 968, 858, 818, 749, 711 cm–1. HRMS (EI): 
Calcd for C28H24O3 [M+ ]: 408.1725. Found: 408.1727. 
 
(E)-6-(Benzyloxy)-2,2-dimethyl-4-hexen-3-yl benzoate (1j) 
Starting from 4.6 mmol of 4j, almost pure 5j (866 mg) was obtained. Then 494 mg of 
the intermediary 5j was used to give 1j (328 mg, 37% for 2 steps) as an oil. 1H NMR 
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(400 MHz, CDCl3): 1.02 (s, 9H), 4.04 (d, J = 4.5 Hz, 2H), 4.50 (s, 2H), 5.28 (d, J = 6.0 
Hz, 1H), 5.84 (dd, J = 6.0, 15.5 Hz, 1H), 5.86 (dt, J = 4.5, 15.5 Hz, 1H), 7.26－7.38 (m, 
5H), 7.45 (dd, J = 7.8, 7.7 Hz, 2H), 7.57 (t, J = 7.8 Hz, 1H), 8.07 (d, J = 7.7 Hz, 2H). 
13C NMR (100 MHz, CDCl3): 25.9, 34.7, 69.7, 71.9, 81.4, 127.5, 127.7, 127.9, 128.3, 
129.5, 130.5, 130.7, 132.8, 138.0, 165.6. IR (neat): 3063, 3031, 2965, 2868, 1718, 1601, 
1452, 1395, 1365, 1316, 1270, 1176, 1111, 1069, 1025, 970, 736, 711 cm–1. HRMS 
(EI): Calcd for C22H26O3 [M+ ]: 338.1882. Found: 338.1878. 
 
(E)-6-(Benzyloxy)-2-methyl-4-hexen-3-yl benzoate (1k) 
Starting from 7.4 mmol of 4k, almost pure 5k (1.58 g) was obtained. Then 547 mg of 
the intermediary 5k was used to give 1k (528 mg, 57% for 2 steps) as an oil. 1H NMR 
(400 MHz, CDCl3): 1.00 (d, J = 6.9, 3H), 1.01 (d, J = 6.4, 3H), 1.99－2.10 (m, 1H), 
4.04 (d, J = 5.5 Hz, 2H), 4.50 (s, 2H), 5.35 (t, J = 6.4 Hz, 2H), 5.80 (dd, J = 16.5, 6.4 
Hz, 1H), 5.87 (dt, J = 16.5, 5.5 Hz, 1H), 7.26－7.58 (m, 8H), 8.06 (d, J = 8.2 Hz, 2H). 
13C NMR (100 MHz, CDCl3): 18.0, 18.2, 32.2, 69.8, 72.0, 78.9, 127.5, 127.7, 128.2, 
128.3, 129.1, 129.5, 130.0, 132.8, 138.0, 165.7. IR (neat): 3063, 3031, 2965, 2873, 1717, 
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1601, 1584, 1494, 1452, 1387, 1368, 1270, 1176, 1111, 1069, 1025, 971, 738, 712 cm–1. 
HRMS (EI): Calcd for C21H24O3 [M+ ]: 324.1725. Found: 324.1721. 
 
Representative Procedure for Sequential 1,4-Elimination Reaction and [1,2]-Wittig 
Rearrangement of (E)-2-Butenyl Benzoate 1a (Table 2, Entry 1). To a mixture of 
powdered KOH (21 mg, 1.05 mmol) and [Pd(dppe)2] (16 mg, 0.018 mmol) was added 
compound 1a (125 mg, 0.35 mmol) in THF (12 mL) dropwise at room temperature and 
the reaction mixture was stirred for 18 h. After MS4A was added and the resulting 
mixture was stirred for 30 min, the mixture was cooled to 0 °C and n-BuLi (1.27 mL of 
1.62 M solution in hexane, 2.1 mmol) was added. After 5 min, the reaction mixture was 
quenched with a sat. aq solution of NH4Cl. The aqueous layer was separated and 
extracted with Et2O. The combined organic extracts were washed with H2O, brine, and 
dried over Na2SO4. The crude product was purified by silica gel column 
chromatography (hexane/AcOEt = 10/1 with 1% Et3N) to give 2a (56 mg, 68%, Z/E = 
>20/1) as an oil. 
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In a similar manner, (2Z,4E)-2,4-pentadien-1-ols 2b–2k were obtained from 1b–1k. 
 
(2Z,4E)-1,5-Diphenyl-2,4-pentadien-1-ol (2a)24 
1H NMR (400 MHz, CDCl3): δ 2.04 (br s, 1H), 5.69 (dd, J = 11.0, 8.7 Hz, 1H), 5.81 (d, 
J = 8.7 Hz, 1H), 6.30 (t, J = 11.0 Hz, 1H), 6.64 (d, J = 15.5 Hz, 1H), 7.21 (dd, J = 15.5, 
11.0 Hz, 1H), 7.26－7.45 (m, 10H). 13C NMR (100 MHz, CDCl3): δ 70.0, 123.6, 125.9, 
126.6, 127.5, 127.9, 128.5, 128.6, 130.1, 133.1, 134.9, 136.9, 143.1. IR (neat): 3366, 
3027, 1599, 1492, 1449, 1280, 1073, 1027, 986, 945, 859, 740, 697 cm–1. HRMS (EI): 
Calcd for C17H16O [M+]: 236.1201. Found: 236.1207. 
During the optimization of the reaction conditions, a mixture of (2Z,4E)-2a and 
(2E,4E)-isomer was obtained as shown in Table 1. Selected NMR data for the 
(2E,4E)-isomer:25 δ 5.32 (d, J = 6.4 Hz, 1H), 6.00 (dd, J = 15.1, 6.4 Hz, 1H), 6.47 (dd, J 
= 15.1, 10.5 Hz, 1H), 6.58 (d, J = 15.6 Hz, 1H), 6.78 (dd, J = 15.6, 10.5 Hz, 1H). 
 
(2Z,4E)-1-(2-Methylphenyl)-5-phenyl-2,4-pentadien-1-ol (2b) 
2b (56 mg, 65% from 0.35 mmol 1b) was obtained as an oil. 1H NMR (400 MHz, 
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CDCl3): 1.92 (br, 1H), 2.36 (s, 3H), 5.62 (dd, J = 8.7, 11.0 Hz, 1H), 5.95 (d, J = 8.7 Hz, 
1H), 6.28 (t, J = 11.0 Hz, 1H), 6.63 (d, J = 15.6 Hz, 1H), 7.21 (dd, J = 11.0, 15.6 Hz, 
1H), 7.24－7.59 (m, 9H). Selected data of (2E,4E)-isomer; 5.51 (d, J = 6.8 Hz, 1H), 
5.81 (dd, J = 6.4, 15.5 Hz, 1H), 6.43 (dd, J = 11.0, 15.5 Hz, 1H), 6.58 (d, J = 16.0 Hz, 
1H), 6.78 (dd, J = 11.0, 16.0 Hz, 1H). 13C NMR (100 MHz, CDCl3): 19.4, 67.4, 123.3, 
125.3, 126.4, 126.6, 127.5, 128.0, 128.7, 130.4, 130.5, 132.3, 134.9, 135.1, 136.9, 141.2. 
IR (neat): 3440, 3024, 1599, 1489, 1457, 1372, 1241, 1158, 1046, 989, 749, 699 cm–1. 
HRMS (EI): Calcd for C18H18O [M+ ]: 250.1358. Found: 250.1359. 
 
(2Z,4E)-1-(3-Methylphenyl)-5-phenyl-2,4-pentadien-1-ol (2c) 
2c (50 mg, 58% from 0.35 mmol 1c) was obtained as an oil. 1H NMR (400 MHz, 
CDCl3): 1.97 (br, 1H), 2.40 (s, 3H), 5.68 (dd, J = 11.0, 9.1 Hz, 1H), 5.78 (d, J = 9.1 Hz, 
1H), 6.29 (t, J = 11.0 Hz, 1H), 6.63 (d, J = 15.5 Hz, 1H), 7.08－7.12 (m, 1H), 7.23－
7.44 (m, 9H). 13C NMR (100 MHz, CDCl3): 21.5, 70.1, 123.0, 123.4, 126.55, 126.61, 
128.0, 128.4, 128.5, 128.7, 130.2, 133.1, 135.0, 137.0, 138.4, 143.1. IR (neat): 3331, 
3025, 1605, 1489, 1448, 1306, 1152, 1029, 987, 946, 779, 754, 692 cm–1. HRMS (EI): 
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Calcd for C18H18O [M+]: 250.1358. Found: 250.1347. 
 
(2Z,4E)-1-(4-Methylphenyl)-5-phenyl-2,4-pentadien-1-ol (2d) 
2d (55 mg, 63% from 0.35 mmol 1d) was obtained as an oil. 1H NMR (400 MHz, 
CDCl3): 1.95 (br, 1H), 2.34 (s, 3H), 5.69 (dd, J = 11.0, 9.1 Hz, 1H), 5.79 (d, J = 9.1 Hz, 
1H), 6.28 (t, J = 11.0 Hz, 1H), 6.63 (d, J = 15.1 Hz, 1H), 7.16－7.44 (m, 10H). 13C 
NMR (100 MHz, CDCl3): 21.1, 70.0, 123.4, 125.8, 126.6, 127.9, 128.7, 129.3, 130.1, 
133.2, 134.9, 137.0, 137.4, 140.2. IR (neat): 3421, 3024, 2920, 1604, 1512, 1492, 1449, 
1374, 1242, 1178, 1044, 986, 811, 749, 693 cm–1. HRMS (EI): Calcd for C18H18O [M+]: 
250.1358. Found: 250.1363. 
 
(2Z,4E)-1-(4-Methoxyphenyl)-5-phenyl-2,4-pentadien-1-ol (2e) 
2e (66 mg, 71% from 0.35 mmol 1e) was obtained as an oil. 1H NMR (400 MHz, 
CDCl3): 1.92 (br, 1H), 3.80 (s, 3H), 5.71 (dd, J = 11.0, 8.7 Hz, 1H), 5.77 (d, J = 8.7 Hz, 
1H), 6.28 (t, J = 11.0 Hz, 1H), 6.63 (d, J = 15.5 Hz, 1H), 6.90 (d, J = 8.6 Hz, 2H), 7.18 
(dd, J = 15.5, 11.0 Hz, 1H), 7.26－7.44 (m, 7H). Selected data of (2E,4E)-isomer; 5.29 
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(m, 1H), 5.,99 (dd, J = 15.1, 6.4 Hz, 1H), 6.46 (dd, J = 15.1, 10.5 Hz, 1H), 6.57 (d, J = 
15.5 Hz, 1H), 6.78 (dd, J = 15.5, 10.5 Hz, 1H). 13C NMR (100 MHz, CDCl3): 55.3, 69.7, 
114.0, 123.4, 126.6, 127.2, 127.9, 128.6, 129.8, 133.2, 134.8, 135.3, 136.9, 159.1. IR 
(neat): 3382, 3026, 2956, 2834, 1610, 1584, 1509, 1449, 1302, 1247, 1173, 1033, 986, 
946, 862, 830, 741, 692 cm–1. HRMS (ESI-TOF): Calcd for C18H18O2Na [M+Na+]: 
289.1204. Found: 289.1198. 
 
(2Z,4E)-1-(4-Chlorophenyl)-5-phenyl-2,4-pentadien-1-ol (2f) 
2f (59 mg, 63% from 0.35 mmol 2f) was obtained as an oil. 1H NMR (400 MHz, 
CDCl3): 1.98 (br, 1H), 5.62 (dd, J = 9.1, 10.5 Hz, 1H), 5.80 (d, J = 9.1 Hz, 1H), 6.31 (t, 
J = 10.5 Hz, 1H), 6.68 (d, J = 15.5 Hz, 1H), 7.20 (dd, J = 15.5, 10.5 Hz, 1H), 7.25-7.42 
(m, 9H). Selected data of (2E,4E)-isomer; 5.30 (d, J = 6.4 Hz, 1H), 5.94 (dd, J = 15.1, 
6.4 Hz, 1H), 6.46 (dd, J = 15.1, 11.0 Hz, 1H), 6.59 (d, J = 16.0 Hz, 1H), 6.77 (dd, J = 
16.0, 11.0 Hz, 1H). 13C NMR (100 MHz, CDCl3): 69.3, 123.0, 126.6, 127.3, 128.1, 
128.7, 130.6, 132.5, 133.3, 135.5, 136.8, 141.5. IR (neat): 3351, 3027, 1636, 1595, 1489, 
1449, 1400, 1090, 1013, 986, 945, 861, 826, 744, 691 cm–1. HRMS (EI): Calcd for 
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C17H15OCl [M+]: 270.0811. Found: 270.0814. 
 
(2Z,4E)-1-(2-Naphthalenyl)-5-phenyl-2,4-pentadien-1-ol (2g) 
2g (68 mg, 68% from 0.35 mmol 1g) was obtained as an oil. 1H NMR (400 MHz, 
CDCl3): 2.09 (br, 1H), 5.76 (dd, J = 11.0, 8.7 Hz, 1H), 5.98 (d, J = 8.7 Hz, 1H), 6.35 (t, 
J = 11.0 Hz, 1H), 6.67 (d, J = 15.1 Hz, 1H), 7.26－7.55 (m, 9H), 7.81－7.91 (m, 4H). 
13C NMR (100 MHz, CDCl3): 70.2, 123.3, 124.1, 124.3, 125.9, 126.2, 126.6, 127.6, 
128.0, 128.4, 128.7, 130.4, 132.8, 132.9, 133.3, 135.2, 136.8, 140.4. IR (neat): 3447, 
3024, 1599, 1507, 1492, 1449, 1371, 1242, 1158, 1123, 1046, 990, 896, 858, 818, 747, 
693 cm–1. HRMS (EI): Calcd for C21H18O [M+]: 286.1358. Found: 286.1353. 
 
(2Z,4E)-5-(4-Methylphenyl)-1-phenyl-2,4-pentadien-1-ol (2h) 
2h (63 mg, 72% from 0.35 mmol 1h) was obtained as an oil. 1H NMR (400 MHz, 
CDCl3): 1.98 (br, 1H), 2.35 (s, 3H), 5.66 (dd, J = 11.0, 8.7 Hz, 1H), 5.82 (d, J = 8.7 Hz, 
1H), 6.29 (t, J = 11.0 Hz, 1H), 6.61 (d, J = 15.6 Hz, 1H), 7.13－7.48 (m, 10H). 13C 
NMR (100 MHz, CDCl3): 21.3, 70.0, 122.4, 125.9, 126.5, 127.6, 128.6, 129.4, 130.4, 
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132.4, 134.1, 135.0, 138.0, 143.1. IR (neat): 3293, 3023, 1630, 1603, 1509, 1490, 1453, 
1343, 1287, 1191, 1017, 984, 954, 941, 908, 839, 806, 765, 735, 696 cm–1. HRMS (EI): 
Calcd for C18H18O [M+]: 250.1358. Found: 250.1343. 
 
(2Z,4E)-5-(2-Naphthalenyl)-1-phenyl-2,4-pentadien-1-ol (2i) 
2i (67 mg, 67% from 0.35 mmol 1i) was obtained as an oil. 1H NMR (400 MHz, 
CDCl3): 2.05 (br, 1H), 5.73 (dd, J = 11.0, 9.1 Hz, 1H), 5.89 (d, J = 9.1 Hz, 1H), 6.37 (t, 
J = 11.0 Hz, 1H), 6.81 (d, J = 15.6 Hz, 1H), 7.32－7.48 (m, 8H), 7.66 (d, J = 7.8 Hz, 
1H), 7.78－7.81 (m, 4H). Selected data of (2E,4E)-isomer; 5.35 (d, J = 5.9 Hz, 1H), 
6.05 (dd, J = 15.1, 5.9 Hz, 1H), 6.54 (dd, J = 15.1, 9.6 Hz, 1H), 6.74 (d, J = 16.4 Hz, 
1H), 6.88 (dd, J = 16.4, 9.6 Hz, 1H). 13C NMR (100 MHz, CDCl3): 70.1, 123.5, 123.6, 
125.9, 126.1, 126.4, 126.9, 127.6, 127.7, 128.0, 128.3, 128.6, 130.3, 133.10, 133.15, 
133.5, 134.4, 135.2, 143.0. IR (neat): 3397, 3030, 1626, 1600, 1506, 1491, 1454, 1268, 
1115, 1008, 985, 953, 851, 822, 750, 700 cm–1. HRMS (EI): Calcd for C21H18O [M+]: 
286.1358. Found: 286.1363. 
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(2Z,4E)-6,6-Dimethyl-1-phenyl-2,4-heptadien-1-ol (2j) 
2j (44 mg, 53% from 0.35 mmol 1j) was obtained an oil. 1H NMR (400 MHz, CDCl3): 
1.06 (s, 9H), 1.90 (br, 1H), 5.51 (dd, J = 11.0, 8.7 Hz, 1H), 5.72 (d, J = 8.7 Hz, 1H), 
5.83 (d, J = 15.1 Hz, 1H), 6.10 (t, J = 11.0 Hz, 1H), 6.40 (dd, J = 15.1, 11.0 Hz, 1H), 
7.26－7.42 (m, 5H). 13C NMR (100 MHz, CDCl3): 29.4, 33.5, 69.9, 119.5, 125.8, 127.4, 
128.5, 130.5, 130.9, 143.4, 149.0. IR (neat): 3330, 3029, 2959, 2902, 2864, 1650, 1602, 
1493, 1451, 1362, 1267, 1038, 985, 949, 743, 698 cm–1. HRMS (EI): Calcd for C15H20O 
[M+]: 216.1514. Found: 216.1522. 
 
A mixture of 2k and 3 (40 mg, 59% from 0.35 mmol 1k) was obtained as an oil. The 
yields of 2k and 3 were determined by 1H NMR spectrum of their mixture. After further 
separation of 2k and 3 by column chromatography, the physical properties were 
measured. 
(2Z,4E)-6-Methyl-1-phenyl-2,4-heptadien-1-ol (2k) 
2k (34%). 1H NMR (400 MHz, CDCl3): 1.03 (d, J = 6.9 Hz, 3H), 1.04 (d, J = 6.9 Hz, 
3H), 1.89 (br, 1H), 2.35－2.43 (m, 1H), 5.50 (dd, J = 11.0, 8.7 Hz, 1H), 5.70 (d, J = 8.7 
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Hz, 1H), 5.80 (dd, J = 15.1, 6.8 Hz, 1H), 6.10 (t, J = 11.0 Hz, 1H), 6.43 (dd, J = 15.1, 
11.0 Hz, 1H), 7.25－7.42 (m, 5H). 13C NMR (100 MHz, CDCl3): 22.20, 22.21, 31.4, 
69.9, 121.8, 125.8, 127.5, 128.5, 130.5, 130.7, 143.4, 145.1. IR (neat): 3331, 3026, 2958, 
2924, 1696, 1601, 1540, 1493, 1452, 1377, 1028, 986, 853, 746, 669 cm–1. HRMS (EI): 
Calcd for C14H18O [M+]: 202.1358. Found: 202.1367. 
 
(E)-6-Methyl-1-phenyl-3,5-heptadien-1-ol (3) 
3k (25%). 1H NMR (400 MHz, CDCl3): 1.75 (s, 3H), 1.78 (s, 3H), 1.79 (br, 1H), 2.80 
(ddd, J = 13.2, 12.4, 6.8 Hz, 1H), 2.89 (dd, J = 13.2, 5.0 Hz, 1H), 4.40 (dd, J = 12.4, 5.0 
Hz, 1H), 5.62 (dd, J = 15.1, 6.8 Hz, 1H), 5.82 (d, J = 11.0 Hz, 1H), 6.44 (dd, J = 15.1, 
11.0 Hz, 1H), 7.20－7.26 (m, 3H), 7.29－7.33 (m, 2H). 13C NMR (100 MHz, CDCl3): 
18.3, 26.0, 44.3, 76.7, 124.2, 126.5, 127.4, 128.5, 129.6, 132.0, 136.3, 137.9. IR (neat): 
3404, 3026, 2922, 2855, 1659, 1602, 1494, 1453, 1376, 1260, 1094, 1029, 986, 959, 
868, 801, 746, 700 cm–1. HRMS (ESI-TOF): Calcd for C14H18ONa [M+Na+]: 225.1255. 
Found: 225.1255. 
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Supporting Information 
1H NMR and 13C NMR spectra of compounds 1–4. This material is available free of 
charge via the Internet at http://pubs.acs.org/. 
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